COVID-19 VACCINE APPOINTMENTS & INFO

Updated as of July 20, 2021

Stony Brook Children's will be administering first dose Pfizer vaccinations to those 12 years and older on Wednesday, August 4 from  8 a.m. to 4 p.m. at the Hampton Bays Middle School (70 Ponquogue Avenue in Hampton Bays). Appointments are required. To schedule and complete a consent form, visit bit.ly/hbvaccine2021. Identification and proof of age are required. A parent or guardian must be present for those who are 12 to 17 years. Please wear a short sleeved shirt (for ease of injection access). Masks and social distancing are mandated. The second Pfizer dose will be scheduled at the same location on Wednesday, August 25.

The NY State POD on the Stony Brook Southampton Campus is vaccinating all people 12 years and older every day through Monday, July 26. No appointments are necessary, you may walk in. Hours are Mondays, Thursdays, Fridays and Saturdays 8 a.m. to 6:30 p.m.; Tuesdays and Thursdays 10:45 a.m. to 9:30 p.m.; and Sundays 8 a.m. to 12:00 p.m. (noon).  Please help protect yourself and loved ones by getting vaccinated. Monday, July 26 is the last day Campus NY State POD will be administering vaccinations. 

Individuals 12 years and older are eligible to be vaccinated with Pfizer and 18 years and older can be vaccinated with MODERNA. You can now walk-in to any NYS POD. For more information, please visit the  New York State Department of Health "AM I ELIGIBLE"  app at https://am-i-eligible.covid19vaccine.health.ny.gov/ or the New York Vaccination Hotline: 1-833-NYS-4VAX (1-833-697-4829).   If you have any questions about this process, you can find additional information HERE   (If you are having difficulty accessing the AM I ELIGIBLE app, switch your browser to Google Chrome or Firefox)

CDC and FDA Lift Pause on the Johnson & Johnson Vaccine: Following a thorough safety review, the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) have lifted their recommendation to pause the administration of the Johnson & Johnson/Janssen (J&J) COVID-19 vaccine on April 23, allowing for the use of the J&J vaccine to resume in the U.S. The CDC and FDA determined that the J&J vaccine’s known and potential benefits outweigh its known and potential risks. The two agencies will continue to monitor the safety of all COVID-19 vaccines. For more information about the J&J vaccine, visit the CDC website. If you have questions about any of the COVID-19 vaccines, you should speak with your healthcare provider